Bile acid derivatives as FXR ligands for the prevention or treatment of FXRmediated diseases or conditions

Details for Australian Patent Application No. 2007215207 (hide)

Owner Intercept Pharmaceuticals, Inc.

Inventors Pellicciari, Roberto; Pruzanski, Mark; Fiorucci, Stefano

Agent Peter Maxwell & Associates

Pub. Number AU-A-2007215207

PCT Pub. Number WO2007/095174

Priority 60/772,900 14.02.06 US

Filing date 14 February 2007

Wipo publication date 23 August 2007

International Classifications

C07J 9/00 (2006.01) Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

C07J 41/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing nitrogen

Event Publications

4 September 2008 PCT application entered the National Phase

  PCT publication WO2007/095174 Priority application(s): WO2007/095174

24 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007215211-Methoxypolyethylene glycol thioester chelate and uses thereof

2007215183-Special application sprinkler for use in fire protection